Chardan Capital Initiates Coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (MUN:260) with Buy Recommendation
Fintel reports that on May 8, 2025, Chardan Capital initiated coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (MUN:260) with a Buy recommendation.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
